137 related articles for article (PubMed ID: 34542130)
1. Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D models.
Xu J; Gu M; Hooi L; Toh TB; Thng DKH; Lim JJ; Chow EK
Nanoscale; 2021 Oct; 13(38):16131-16145. PubMed ID: 34542130
[TBL] [Abstract][Full Text] [Related]
2. Polyamidoamine-Decorated Nanodiamonds as a Hybrid Gene Delivery Vector and siRNA Structural Characterization at the Charged Interfaces.
Lim DG; Rajasekaran N; Lee D; Kim NA; Jung HS; Hong S; Shin YK; Kang E; Jeong SH
ACS Appl Mater Interfaces; 2017 Sep; 9(37):31543-31556. PubMed ID: 28853284
[TBL] [Abstract][Full Text] [Related]
3. Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma Therapy.
Gu M; Toh TB; Hooi L; Lim JJ; Zhang X; Chow EK
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45427-45441. PubMed ID: 31718136
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma.
Yao Y; Wang T; Liu Y; Zhang N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1374-1383. PubMed ID: 30977418
[TBL] [Abstract][Full Text] [Related]
5. Nanodiamond as a vector for siRNA delivery to Ewing sarcoma cells.
Alhaddad A; Adam MP; Botsoa J; Dantelle G; Perruchas S; Gacoin T; Mansuy C; Lavielle S; Malvy C; Treussart F; Bertrand JR
Small; 2011 Nov; 7(21):3087-95. PubMed ID: 21913326
[TBL] [Abstract][Full Text] [Related]
6. Plasma hydrogenated cationic detonation nanodiamonds efficiently deliver to human cells in culture functional siRNA targeting the Ewing sarcoma junction oncogene.
Bertrand JR; Pioche-Durieu C; Ayala J; Petit T; Girard HA; Malvy CP; Le Cam E; Treussart F; Arnault JC
Biomaterials; 2015 Mar; 45():93-8. PubMed ID: 25662499
[TBL] [Abstract][Full Text] [Related]
7. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
8. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma.
Gao J; Yu Y; Zhang Y; Song J; Chen H; Li W; Qian W; Deng L; Kou G; Chen J; Guo Y
Biomaterials; 2012 Jan; 33(1):270-82. PubMed ID: 21963149
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake and fate of cationic polymer-coated nanodiamonds delivering siRNA: a mechanistic study.
Majer J; Kindermann M; Pinkas D; Chvatil D; Cigler P; Libusova L
Nanoscale; 2024 Feb; 16(5):2490-2503. PubMed ID: 38197438
[TBL] [Abstract][Full Text] [Related]
10. Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.
Scarabel L; Perrone F; Garziera M; Farra R; Grassi M; Musiani F; Russo Spena C; Salis B; De Stefano L; Toffoli G; Rizzolio F; Tonon F; Abrami M; Chiarappa G; Pozzato G; Forte G; Grassi G; Dapas B
Expert Opin Drug Deliv; 2017 Jun; 14(6):797-810. PubMed ID: 28266887
[TBL] [Abstract][Full Text] [Related]
11. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
Yin T; Wang P; Li J; Wang Y; Zheng B; Zheng R; Cheng D; Shuai X
Biomaterials; 2014 Jul; 35(22):5932-43. PubMed ID: 24746965
[TBL] [Abstract][Full Text] [Related]
12. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM
Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
14. Lysine-functionalized nanodiamonds as gene carriers: development of stable colloidal dispersion for in vitro cellular uptake studies and siRNA delivery application.
Alwani S; Kaur R; Michel D; Chitanda JM; Verrall RE; Karunakaran C; Badea I
Int J Nanomedicine; 2016; 11():687-702. PubMed ID: 26929623
[TBL] [Abstract][Full Text] [Related]
15. Design of Smart Nanodiamonds: Introducing pH Sensitivity to Improve Nucleic Acid Carrier Efficiency of Diamoplexes.
Alwani S; Rai R; Zittlau I; Rekve J; Michel D; Badea I
Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145542
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of aptamer-carbon dot nanomaterial-siRNA complex on the metastasis of hepatocellular carcinoma cells by interfering with FMRP.
Zhao X; Yang J; Zhang J; Wang X; Chen L; Zhang C; Shen Z
Eur J Pharm Biopharm; 2022 May; 174():47-55. PubMed ID: 35364257
[TBL] [Abstract][Full Text] [Related]
17. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.
Futami K; Ogasawara S; Goto H; Yano H; Furuichi Y
Int J Mol Med; 2010 Apr; 25(4):537-45. PubMed ID: 20198302
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and improved anticancer effect of NIK-siRNA in combination with 5-FU for hepatocellular carcinoma.
Kang SS; Cho HA; Kim JS
Arch Pharm Res; 2011 Jan; 34(1):79-86. PubMed ID: 21468918
[TBL] [Abstract][Full Text] [Related]
19. Small interfering RNA-mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma.
Hajiasgharzadeh K; Somi MH; Shanehbandi D; Mokhtarzadeh A; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3263-3276. PubMed ID: 30362510
[TBL] [Abstract][Full Text] [Related]
20. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.
Bi Y; Zhang Y; Cui C; Ren L; Jiang X
Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
